Optimal management of lymph node-positive (cN+) prostate cancer (PCa) remains largely undefined given a lack of prospective, randomized data to inform practice. However, results from a recent study found patients at high-risk for prostate cancer significantly benefited from treatment with androgen deprivation therapy (ADT). {read more here}